Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.

Allergy - 1 Nov 2018

Craig Timothy J, Henao Maria Paula

Abstract excerpt

α1 -Antitrypsin deficiency (AATD) predisposes individuals to chronic obstructive pulmonary disease (COPD) and liver disease. Despite being commonly described as rare, AATD is under-recognized, with less than 10% of cases identified. The following is a comprehensive review of AATD, primarily for physicians who treat COPD or asthma, covering the genetics, epidemiology, clinical presentation, screening and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diagnostic Imaging

Share to Disease Management

Share to Genetic Association Studies

Share to Pulmonary Disease, Chronic Obstructive

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 29984428
DOI: 10.1111/all.13558
PMCID: PMC6282978

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.PMID 29984428Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency: outstanding questions and future directionsSemantic proximity Read ↗

Alpha-1 antitrypsin deficiency: whom to test, whom to treat?Semantic proximity Read ↗

Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency.Semantic proximity Read ↗

The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiencySemantic proximity Read ↗

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Semantic proximity Read ↗

Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlookSemantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1-antitrypsin deficiency.Semantic proximity Read ↗

Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.